Aileron Therapeutics Inc

-0.01 (-1.56%)
Earnings Announcements

Aileron Therapeutics Reports Q3 Loss Per Share $0.07

Published: 11/12/2021 12:58 GMT
Aileron Therapeutics Inc (ALRN) - Aileron Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights.
Q3 Loss per Share $0.07.
Q3 Earnings per Share View $-0.07 -- Refinitiv Ibes Data (analyst estimates).
$52.2 Million Cash and Cash Equivalents As of September 30, 2021, Expected to Fund Operations Into Second Half of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.08

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.